These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33010699)

  • 21. Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients.
    Sornmayura P; Rerkamnuaychoke B; Jinawath A; Euanorasetr C
    J Med Assoc Thai; 2012 Jan; 95(1):88-95. PubMed ID: 22379747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaching heterogeneity of human epidermal growth factor receptor 2 in surgical specimens of gastric cancer.
    Asioli S; Maletta F; Verdun di Cantogno L; Satolli MA; Schena M; Pecchioni C; Botta C; Chiusa L; Molinaro L; Conti L; Viale G; Ingravallo G; Maiorano E; Sapino A
    Hum Pathol; 2012 Nov; 43(11):2070-9. PubMed ID: 22658277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India.
    Nadaf AS; Rani H; Dinesh US
    Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
    Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M
    Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor containing fragment number influences immunohistochemistry positive rate of HER2 in biopsy specimens of gastric cancer.
    Xu C; Liu Y; Ge X; Jiang D; Zhang Y; Ji Y; Hou J; Huang J; Su J; Zeng H; Qin J; Hou Y
    Diagn Pathol; 2017 May; 12(1):41. PubMed ID: 28549444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
    Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
    Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A large cohort of consecutive patients confirmed frequent HER2 positivity in gastric carcinomas with advanced stages.
    Cho J; Jeong J; Sung J; Sung CO; Kim KM; Park CK; Choi MG; Sohn TS; Bae JM; Kim S
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S477-84. PubMed ID: 23274580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter large-scale study of prognostic impact of HER2 expression in patients with resectable gastric cancer.
    Kurokawa Y; Matsuura N; Kimura Y; Adachi S; Fujita J; Imamura H; Kobayashi K; Yokoyama Y; Shaker MN; Takiguchi S; Mori M; Doki Y
    Gastric Cancer; 2015 Oct; 18(4):691-7. PubMed ID: 25224659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice.
    Grillo F; Fassan M; Sarocchi F; Fiocca R; Mastracci L
    World J Gastroenterol; 2016 Jul; 22(26):5879-87. PubMed ID: 27468182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological features and endoscopic findings of HER2-positive gastric cancer.
    Oono Y; Kuwata T; Takashima K; Yoda Y; Ikematsu H; Shitara K; Kinoshita T; Yano T
    Surg Endosc; 2018 Sep; 32(9):3964-3971. PubMed ID: 29500656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma.
    Kim H; Seo S; Kim K; Park YH; An M; Baik H; Choi C; Oh S
    World J Surg Oncol; 2019 Jul; 17(1):122. PubMed ID: 31296222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The clinicopathological parameters and prognostic significance of HER2 expression in gastric cancer patients: a meta-analysis of literature.
    Lei YY; Huang JY; Zhao QR; Jiang N; Xu HM; Wang ZN; Li HQ; Zhang SB; Sun Z
    World J Surg Oncol; 2017 Mar; 15(1):68. PubMed ID: 28327158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined HER2 analysis of biopsies and surgical specimens to optimize detection of trastuzumab-eligible patients in eso-gastric adenocarcinoma: a GERCOR study.
    Watson S; Validire P; Cervera P; Zorkani N; Scriva A; Lemay F; Tournigand C; Perniceni T; Garcia ML; Bennamoun M; Paye F; Louvet C
    Ann Oncol; 2013 Dec; 24(12):3035-9. PubMed ID: 24114855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance.
    Yu GZ; Chen Y; Wang JJ
    J Cancer Res Clin Oncol; 2009 Oct; 135(10):1331-9. PubMed ID: 19337752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HER2 testing in paired biopsy and excision specimens of gastric cancer: the reliability of the scoring system and the clinicopathological factors relevant to discordance.
    Huang SC; Ng KF; Lee SE; Chen KH; Yeh TS; Chen TC
    Gastric Cancer; 2016 Jan; 19(1):176-82. PubMed ID: 25512144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
    Koopman T; Smits MM; Louwen M; Hage M; Boot H; Imholz AL
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1343-51. PubMed ID: 25544671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HER2 Expression Status and Prognostic, Diagnostic, and Demographic Properties of Patients with Gastric Cancer: a Single Center Cohort Study from Iran.
    Feizy A; Karami A; Eghdamzamiri R; Moghimi M; Taheri H; Mousavinasab N
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1721-1725. PubMed ID: 29938472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin receptor subtype 2 A (SSTR2A) and HER2 expression in gastric adenocarcinoma.
    Romiti A; Di Rocco R; Milione M; Ruco L; Ziparo V; Zullo A; Duranti E; Sarcina I; Barucca V; D'Antonio C; Marchetti P
    Anticancer Res; 2012 Jan; 32(1):115-9. PubMed ID: 22213295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human epidermal growth factor receptor 2 expression in gastric carcinoma and its association with histopathological parameters in Indian population.
    Gupta P; Rao S; Bhalla S
    Indian J Cancer; 2016; 53(4):505-511. PubMed ID: 28485339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of Expression of Human Epidermal Growth Factor Receptor 2 (HER2) in Gastric and Gastroesophageal Junction Adenocarcinoma Using IHC and Dual-ISH.
    Dominguez C; Rosa M; George TB; Pimiento J; Lauwers GY; Coppola D
    Anticancer Res; 2018 Jan; 38(1):367-372. PubMed ID: 29277796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.